Home » Newsletters » BioWorld Science

BioWorld Science

April 25, 2005

View Archived Issues

Ondansetron reported to improve memory function in schizophrenia

Trabectedin shows antitumor activity in relapsed or refractory ovarian carcinoma

Corlux prevents olanzapine-induced weight gain in rats

Enrollment completed in phase III study of Thymitaq for HCC

A new immunostimulat from intestinal Eimeria

Early termination of phase III study of gefitinib for advanced lung cancer

Debiopharm and NanoCarrier form platinum compound research collaboration

Shire to acquire Transkaryotic Therapies

Trexima achieves endpoints in second phase III trial

Progression of pivotal study of MBP-8298 for secondary progressive MS

Evaluation of peptide deformylase inhibitor LBM-415's antimicrobial activity / News in Context

ST-294: Orally bioavailable small-molecule antiviral agent for New World Arenaviruses

Preclinical results from lead smallpox drug ST-246

BioCurex's RECAF blood test detects 92% of cervical cancers

Guilford restarts Aquavan program

SX-007 prolongs survival of mice with glioblastoma

FXa inhibitor reduces metastasis without anticoagulant-associated side effects

New patents cover treatments for cancer

Agreement on label wording for 5 mg dose of Crestor in Europe

MP-412: a promising compound for the treatment of EGFR/HER2-expressing tumors

Positive opinion handed down in Europe for new Temodal indication

Preclinical studies demonstrate that CYT-997 is a promising antitumor candidate

Preclinical antitumor activity of phase I PharmaMar compound

Eisai synthesizes novel antimitotic agent related to hemiasterlin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...